Australia's RSV Vaccine Cuts Baby Hospitalizations by 80%

Australian babies are getting powerful protection against a common virus that used to send thousands of infants to the hospital every year. A new study shows that a maternal RSV vaccine is cutting hospitalization risk by 80% for babies under six months old.

Respiratory syncytial virus sounds technical, but every parent knows its impact. It's the virus that fills children's hospitals each winter, putting tiny babies on breathing support and keeping families in scary vigils by hospital beds.

Now researchers from The Kids Research Institute Australia have confirmed what doctors are seeing in their clinics. The maternal vaccine, introduced through Australia's National Immunisation Program in early 2025, is keeping babies safe during their most vulnerable months.

The study tracked over 1,000 infants at nine Australian hospitals from March 2025 to February 2026. Among babies hospitalized with respiratory illness, those whose mothers received the vaccine during pregnancy were 80% less likely to test positive for RSV.

The protection was even stronger for the tiniest patients. For babies under two months old, when RSV can be most dangerous, the vaccine prevented 86% of hospitalizations from RSV-related lower respiratory tract disease.

Dr. Tim Jones, who chairs the Royal Australian College of General Practitioners' child health group, is seeing the change firsthand. "We are still seeing just as much RSV in our kids this year," he told reporters. "What we are not seeing is as many kids needing to go to hospital and certainly not as many kids ending up in intensive care, and that is wonderful."

The vaccine requires just one shot during the third trimester of pregnancy. For babies whose mothers didn't receive it, a backup option using monoclonal antibodies is available through state programs.

The Ripple Effect

The success is building something hospitals desperately need: more capacity. Fewer RSV cases means more beds available for other sick children and less strain on pediatric intensive care units during peak season.

It's also strengthening vaccine confidence at a crucial time. "When a vaccine is relatively new, it is understandable that some parents will have questions," said Dr. Ka-Kiu Cheung, who chairs the RACGP's antenatal care group. Seeing real results in their own communities helps families feel confident in their choices.

The program is connecting with parents emotionally too. "They all know someone whose baby has ended up in hospital in its first few months of life," Jones noted. That shared experience is creating real willingness to protect the most vulnerable.

Doctors say there's still work ahead to reach every pregnant person. Some miss the vaccine simply because it gets overlooked during busy maternity appointments. But the message is getting through, and Australian babies are breathing easier because of it.

Protecting the smallest among us turns out to be simpler than we thought: one shot, given with love.